Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval
The Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read More
intranasal vaccine